| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JAD.2004.05.017 |
| P698 | PubMed publication ID | 15571784 |
| P2093 | author name string | David B Henry | |
| Mani N Pavuluri | |||
| Philip G Janicak | |||
| Julie A Carbray | |||
| Michael W Naylor | |||
| Gwendolyn Sampson | |||
| P921 | main subject | risperidone | Q412443 |
| P304 | page(s) | S103-11 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Journal of Affective Disorders | Q15716493 |
| P1476 | title | Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania | |
| P478 | volume | 82 Suppl 1 |
| Q92897423 | Bipolar Disorder Among Children and Adolescents |
| Q37183308 | Child psychopharmacology: Is it more similar than different from adult psychopharmacology? |
| Q38113748 | Combination pharmacotherapy for psychiatric disorders in children and adolescents: prevalence, efficacy, risks and research needs |
| Q37667267 | Comparison of the Addition of Siberian Ginseng (Acanthopanax senticosus) Versus Fluoxetine to Lithium for the Treatment of Bipolar Disorder in Adolescents: A Randomized, Double-Blind Trial |
| Q41686490 | Comparison of the effect of lithium plus quetiapine with lithium plus risperidone in children and adolescents with bipolar I disorder: a randomized clinical trial |
| Q35236982 | Current research in child and adolescent bipolar disorder. |
| Q46494857 | Divalproex sodium for pediatric mixed mania: a 6-month prospective trial |
| Q35036780 | Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder |
| Q34455825 | Double‐blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder |
| Q88561246 | Effectiveness, Adverse Effects and Drug Compliance of Long-Acting Injectable Risperidone in Children and Adolescents |
| Q35242995 | High level of persistence of pediatric bipolar-I disorder from childhood onto adolescent years: a four year prospective longitudinal follow-up study |
| Q92843449 | Maintenance Pharmacological Treatment of Juvenile Bipolar Disorder: Review and Meta-Analyses |
| Q36639919 | Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials |
| Q36284465 | Management options for bipolar disorder in children and adolescents |
| Q37577322 | Managing bipolar disorders in children and adolescents |
| Q34329829 | Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients |
| Q51901162 | Outcomes for youths with early- and very-early-onset bipolar I disorder. |
| Q36634438 | Pharmacological interventions for bipolar youth: developmental considerations |
| Q34158663 | Pharmacological treatment of bipolar disorder among children and adolescents |
| Q36909255 | Pharmacotherapeutic strategies for pediatric bipolar disorder |
| Q46185243 | Pharmacotherapy in bipolar disorders during childhood and adolescence |
| Q50883811 | Pharmacotherapy in the community-based treatment of children with bipolar I disorder. |
| Q27027052 | Pharmacotherapy of bipolar disorder in children and adolescents: an update |
| Q37742068 | Pharmacotherapy of bipolar disorder in children and adolescents: recent progress |
| Q36720669 | Post-acute effectiveness of lithium in pediatric bipolar I disorder |
| Q22242775 | Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder |
| Q39285492 | Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder. |
| Q38218213 | Practitioner review: Long-term pharmacological treatment of pediatric bipolar disorder |
| Q33819889 | Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic |
| Q37880651 | Priority mental health disorders of children and adolescents in primary-care pediatric settings in India 2: diagnosis, pharmacological treatment and referral |
| Q37768441 | Psychopharmacology of pediatric bipolar disorder. |
| Q36648780 | Psychopharmacology of pediatric bipolar disorder: a review |
| Q37088378 | Psychosocial functioning, familiality, and psychiatric comorbidity in bipolar youth with and without psychotic features |
| Q39701332 | Release property study on the novel divalproex sodium enteric-coated capsules |
| Q36613868 | Review of antipsychotics in children and adolescents |
| Q36836750 | Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia |
| Q35978923 | Risperidone and divalproex differentially engage the fronto-striato-temporal circuitry in pediatric mania: a pharmacological functional magnetic resonance imaging study |
| Q33664736 | The Use of Antiepileptic Drugs (AEDs) for the Treatment of Pediatric Aggression and Mood Disorders |
| Q36771995 | The public health aspects of bipolar disorder in children and adolescents |
| Q36979293 | The use of antipsychotics in children and adolescents with bipolar disorders |
| Q36669178 | Treatments in child and adolescent bipolar disorders |
| Q37004421 | Valproate use in children and adolescents with bipolar disorder |
| Q81052383 | [Aatypical antipsychotics in child and adolescent psychiatry--indications apart from schizophrenia] |
Search more.